Celastrol-loaded ginsenoside Rg3 liposomes boost immunotherapy by remodeling obesity-related immunosuppressive tumor microenvironment in melanoma
Acta Pharmaceutica Sinica B · 2025-05 · 15 (5) · 2687-2702
DOI: 10.1016/j.apsb.2025.03.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-05. Verfasst von Hongyan Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Zhejiang Chinese Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Obesity usually exacerbates the immunosuppressive tumor microenvironment (ITME), hindering CD8+ T cell infiltration and function, which further represents a significant barrier to the efficacy of immunotherapy. Herein, a multifunctional liposomal system (CR-Lip) for encapsulating celastrol (CEL) was utilized to remodel obesity-related ITME and improve cancer immunotherapy, wherein Ginsenoside Rg3 (Rg3) was detected interspersed in the phospholipid bilayer and its glycosyl exposed on the surface of the liposome. CR-Lip had a relatively uniform size (116.5 nm), facilitating favorable tumor tissue accumulation through the interaction between Rg3 and glucose transporter 1 overexpressed in obese tumor cells. Upon reaching the tumor region, CR-Lip was found to induce the immunogenic cell death (ICD) of HFD tumor cells. Notably, the level of PHD3 in HFD tumor cells was effectively boosted by CR-Lip to effectively block metabolic reprogramming and increase the availability of major free fatty acids fuel sources. In vivo, experiments studies revealed that the easy-obtained nano platform stimulated enhanced the production of various cytokines in tumor tissues, DC maturation, CD8+ T-cell infiltration, and synergistic anticancer therapeutic potency with aPD-1 (tumor inhibition rate = 82.1%) towards obesity-related melanoma. Consequently, this study presented an efficacious approach to tumor immunotherapy in obese mice by encompassing tumor eradication, inducing ICD, and reprogramming metabolism. Furthermore, it offered a unique insight into a valuable attempt at the immunotherapy of obesity-associated related tumors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
- Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
- Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
- Department of Pharmacy, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310053, China.
Förderung
- Natural Science Foundation of Zhejiang Province
- Zhejiang Chinese Medical University
- National Natural Science Foundation of China
Zitieren
APA
Zhang, H., Huang, J., Li, Y., Jin, W., Wei, J., Ma, N., Shen, L., Gu, M., Mu, C., Xu, D., & Xiong, Y. (2025). Celastrol-loaded ginsenoside Rg3 liposomes boost immunotherapy by remodeling obesity-related immunosuppressive tumor microenvironment in melanoma. Acta Pharmaceutica Sinica B, 15(5), 2687-2702. https://doi.org/10.1016/j.apsb.2025.03.017
Vancouver
Zhang H, Huang J, Li Y, Jin W, Wei J, Ma N, et al. Celastrol-loaded ginsenoside Rg3 liposomes boost immunotherapy by remodeling obesity-related immunosuppressive tumor microenvironment in melanoma. Acta Pharmaceutica Sinica B. 2025;15(5):2687-2702. doi:10.1016/j.apsb.2025.03.017
BibTeX
@article{Zhang2025,
author = {Zhang, Hongyan and Huang, Jingyi and Li, Yujie and Jin, Wanyu and Wei, Jiale and Ma, Ninghui and Shen, Limei and Gu, Mancang and Mu, Chaofeng and Xu, Donghang and Xiong, Yang},
title = {Celastrol-loaded ginsenoside Rg3 liposomes boost immunotherapy by remodeling obesity-related immunosuppressive tumor microenvironment in melanoma},
journal = {Acta Pharmaceutica Sinica B},
year = {2025},
volume = {15},
number = {5},
pages = {2687--2702},
doi = {10.1016/j.apsb.2025.03.017}
}
EUVIMED